Electrocomponents plc Appoint David Sleath as Non-Executive Director

Electrocomponents PLC

Electrocomponents plc (LON:ECM) today announced the appointment of David Sleath as Non-Executive Director of the Company effective on 1 June 2019. He will also be a member of the Nomination, Audit and Remuneration Committees.

The Company further announces that after six years of service, John Pattullo will be retiring as Non-Executive Director and Senior Independent Director (SID) on 1 September 2019. David will be taking over as SID from John.

David is currently Chief Executive Officer of SEGRO plc having served as Finance Director since 1 January 2006. Previously, David was Senior Independent Director and Audit Committee Chair of Bunzl plc from 2007 to 2017. He was a board member of the European Public Real Estate Association from 2011 until 2017, and President of the British Property Federation 2016-2017.

Peter Johnson commented: “We are delighted to have David join the Electrocomponents Board. He brings a wealth of international business and plc board experience across multiple sectors and valuable insight into the dynamics of service-led business models.

The Board would also like to express its gratitude to John for his significant contribution over the years. John has been an outstanding Board member as well as Chair of the Remuneration Committee and latterly SID and has also provided me with invaluable support over the years. It has been a pleasure to work with him and we wish him well for the future.”

Share on:

Latest Company News

Genflow Biosciences reports early findings from SIRT6 gene therapy study

Genflow Biosciences reports early findings from its SIRT6 gene therapy study in older dogs, with further monitoring planned over...

Ilika CEO to discuss battery gigafactory development at Barcelona industry forum

Ilika CEO Graeme Purdy is set to speak at the December 2026 Barcelona battery gigafactory forum, bringing the company's...

Investors demand clear returns as AI spending comes under scrutiny

Investors are demanding clearer returns from AI spending as technology shares face pressure, with corporate earnings, data centre investment...

Novo Nordisk deal puts focus on next generation of oral GLP-1 treatments

Novo Nordisk secures rights to Hengrui's investigational HRS-1596 in a potential $2.6bn deal, targeting the development of once-weekly oral...

itim Group targets retail AI market with new platform launch

ITIM Group is targeting the retail AI market with itimAIQ, a new platform designed to automate operations, improve efficiency...

Drax sets date for 2026 Capital Markets Day and trading update

Drax Group will host its Capital Markets Day on 23 November 2026, providing investors and analysts with a management...

    Search